Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €250.75 EUR
Change Today +0.50 / 0.20%
Volume 16.7K
ERF On Other Exchanges
EN Paris
EN Paris
As of 11:35 AM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

eurofins scientific (ERF) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/20/15 - €261.15
52 Week Low
10/16/14 - €163.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for EUROFINS SCIENTIFIC (ERF)

Related News

No related news articles were found.

eurofins scientific (ERF) Related Businessweek News

No Related Businessweek News Found

eurofins scientific (ERF) Details

Eurofins Scientific SE provides various analytical testing services to customers primarily in pharmaceutical, food, and environmental sectors worldwide. The company offers a portfolio of approximately 130,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products. It provides food and feed testing services; biopharma services; pharma discovery services, including in vitro pharmacology profiling/screening services, vivo screening services, cell based assay services, and toxicity and pharmacokinetics services; preclinical services and early development Phase I and IIa studies; bioanalytical services; biomarker analysis services; pharmacogenetic/pharmacogenomics, biological safety testing, and assay development and validation services, as well as project consultancy and management services; and pharma central laboratory services. The company also offers biopharma product testing services; genomic services consisting of DNA and RNA oligonucleotides, custom DNA sequencing, next generation sequencing, gene synthesis and molecular biology, and genotyping and gene expression services; agro science services; consumer product testing services; forensic services, such as forensic DNA analysis and forensic toxicology; and environment testing services comprising water, soil, fuel, building materials, waste, air, and pollution testing services. In addition, it provides REACH testing and REACH consultancy services. The company operates approximately 200 laboratories in 36 countries. Eurofins Scientific SE was founded in 1987 and is headquartered in Luxembourg.

17,144 Employees
Last Reported Date: 02/26/15
Founded in 1987

eurofins scientific (ERF) Top Compensated Officers

Chairman of the Board and Chief Executive Off...
Total Annual Compensation: €720.0K
Group Chief Technology Officer, Executive Dir...
Total Annual Compensation: €203.0K
Compensation as of Fiscal Year 2013.

eurofins scientific (ERF) Key Developments

Eurofins Scientific SA to Report Fiscal Year 2014 Results on Mar 02, 2015

Eurofins Scientific SA announced that they will report fiscal year 2014 results Pre-Market on Mar 02, 2015

Eurofins Scientific SA Announces Earnings Results for the Second Half Year and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year 2015

Eurofins Scientific SA announced earnings results for the second half year and full year ended December 31, 2014. For the half year, the company reported revenues of EUR 766.7 million against EUR 655.3 million a year ago, increased by 15.5% in the fourth quarter. Adjusted EBITDA was EUR 151.4 million against EUR 126.2 million a year ago. Statutory EBITDA was EUR 139.0 million against EUR 110.8 million a year ago. Adjusted EBITDA margin was 19.8% against 19.3% a year ago. Adjusted net profit was EUR 79.3 million or EUR 5.24 per basic share against EUR 71.6 million or EUR 4.77 per basic share a year ago. Statutory net profit was EUR 56.5 million or EUR 3.74 per basic share against EUR 49.7 million or EUR 3.31 per basic share a year ago. For the year, the company reported revenues of EUR 1,410 million against EUR 1,226 million a year ago, up 15.1%. Adjusted EBITDA was EUR 260 million against EUR 219 million a year ago. Statutory EBITDA was EUR 230.0 million against EUR 189.1 million a year ago. Adjusted EBITDA margin was 18.5% against 17.9% a year ago. Adjusted net profit was EUR 128 million or EUR 8.47 per basic share against EUR 117 million or EUR 7.79 per basic share a year ago. Statutory net profit was EUR 79.1 million or EUR 5.23 per basic share against EUR 72.2 million or EUR 4.81 per basic share a year ago. Operating cash flow was EUR 212 million against EUR 169 million a year ago. Capex was EUR 131.2 million compared to EUR 98.7 million a year ago. Net Debt was EUR 493.6 million compared to EUR 386.8 million a year ago. For 2015, the company’s objective is to exceed EUR 1.6 billion of revenues and EUR 300 million in adjusted EBITDA. More importantly, the Group maintains its mid-term objectives of reaching at least EUR 2 billion in revenues and 20% adjusted EBITDA margin by 2017.

Eurofins Scientific SA Proposes Dividends

The Board of Directors of Eurofins Scientific SA proposed to raise the amount of dividends paid out to shareholders by 10% to EUR 1.32 per share.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ERF:FP €250.75 EUR +0.50

ERF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ERF.
View Industry Companies

Industry Analysis


Industry Average

Valuation ERF Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EUROFINS SCIENTIFIC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at